Holter of Movement in Patients with Multiple Sclerosis in Controlled E
Holter of Movement in Patients with Multiple Sclerosis. Acti-SEP Study: Controlled Environment.
What it found
We found no results in the registry or in papers.
This trial finished 5 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Actimyo°
- IMU
What it measured
Main measures
95th centile of stride velocity
One day
50th centile of stride velocity
One day
95th centile of stride length
One day
50th centile of stride length
One day
Stance phase time
One day
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Confirmed MS diagnosis, * Over 18 years old, * Ambulant patients, * Signed informed consent, * No clinical and / or radiological relapse within 3 months.
Exclusion criteria
* Patients with excessive cognitive disorders, limiting the understanding of task or with apparent communication difficulties hindering data collection. * Any other previous or present pathology having an impact on motor function. * Recent surgery or trauma (less than 6 months) in the upper or lower limbs
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be included on a voluntary basis. We plan to include a group of approximately 20 patients with MS. This study include a unique evaluation in the laboratory of analysis of human movement. A set of tasks will be performed by patients wearing of two magneto-inertial sensors.
Papers
Loading reviews and guidelines…
History
Started
Feb 2021
Main results due
Sept 2021
Finished
Sept 2021